| FBCVX | VVIAX | FBCVX / VVIAX | |
| Total Expense Ratio | 0.56 | 0.05 | 1,120% |
| Annual Report Gross Expense Ratio | 0.56 | 0.05 | 1,120% |
| Fund Existence | 22 years | 25 years | - |
| Gain YTD | 5.535 | 9.352 | 59% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 590M | 208B | 0% |
| Annual Yield % from dividends | 1.48 | 2.09 | 71% |
| Returns for 1 year | -2.12 | 5.07 | -42% |
| Returns for 3 years | 8.16 | 30.25 | 27% |
| Returns for 5 years | 43.18 | 62.97 | 69% |
| Returns for 10 years | 66.89 | 123.10 | 54% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| REKT | 18.72 | 0.21 | +1.15% |
| Direxion Daily Crypto Industry Bear1XETF | |||
| GDMN | 80.97 | 0.86 | +1.07% |
| WisdomTree Efcnt Gld Pls Gld Ms Stgy ETF | |||
| QTJL | 37.94 | 0.13 | +0.35% |
| Innovator Growth Accelerated Pls ETF Jul | |||
| ILTB | 50.15 | -0.07 | -0.14% |
| iShares Core 10+ Year USD Bond ETF | |||
| XBI | 114.50 | -0.68 | -0.59% |
| State Street® SPDR® S&P® Biotech ETF | |||